KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Change in Receivables (2016 - 2025)

CareDx (CDNA) has disclosed Change in Receivables for 13 consecutive years, with -$5.3 million as the latest value for Q4 2025.

  • Quarterly Change in Receivables fell 193.31% to -$5.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$22.5 million through Dec 2025, down 263.9% year-over-year, with the annual reading at -$22.5 million for FY2025, 263.9% down from the prior year.
  • Change in Receivables hit -$5.3 million in Q4 2025 for CareDx, up from -$19.6 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $9.2 million in Q1 2024 to a low of -$19.6 million in Q3 2025.
  • Historically, Change in Receivables has averaged $314000.0 across 5 years, with a median of $309500.0 in 2022.
  • Biggest five-year swings in Change in Receivables: skyrocketed 473.19% in 2021 and later crashed 5800.0% in 2025.
  • Year by year, Change in Receivables stood at $2.8 million in 2021, then plummeted by 247.32% to -$4.2 million in 2022, then soared by 84.08% to -$665000.0 in 2023, then tumbled by 172.03% to -$1.8 million in 2024, then tumbled by 193.31% to -$5.3 million in 2025.
  • Business Quant data shows Change in Receivables for CDNA at -$5.3 million in Q4 2025, -$19.6 million in Q3 2025, and -$4.3 million in Q2 2025.